BridgeBio Pharma to Present Additional Phase 3 FORTIFY BBP-418 Interim Data at MDA Clinical and Scientific Conference

Reuters03-04
<a href="https://laohu8.com/S/BBIO">BridgeBio Pharma</a> to Present Additional Phase 3 FORTIFY BBP-418 Interim Data at MDA Clinical and Scientific Conference

BridgeBio Pharma Inc. will present additional interim Phase 3 FORTIFY trial data on BBP-418 in limb-girdle muscular dystrophy type 2I/R9 at the MDA Clinical and Scientific Conference in Orlando, Florida, taking place March 8-11, 2026. More information is available at http://bridgebio.com and on the company’s social channels: LinkedIn https://www.globenewswire.com/Tracker?data=sTkQ6NilfNoC0gIrrW6_4-S40E9HFe62x_ubydIQ9FnXZeK3CDl60WKbvBOmEtuOrvJNWT44WGy7MOoe_XiOEO_b6cQaL-7FXSEVUK2dDaI=, X https://www.globenewswire.com/Tracker?data=Rus_w3fboYED7bVsJ2Nqvqnt6oqI4JRoTk5qyLoVkhIUNUO7W0tZkBEqW9rpAzh_dJivG5q0JDH88nI-cPdIBQ==, Facebook https://www.globenewswire.com/Tracker?data=KrHna-mPQNOUjJBrFGQiu5t0dyWzLMDF2cLFfWr_7i7nqwRUZXDOvglH8QujfpoVIX0-KXx_tm-Mh6cUQ-FSJxsjdmbRQVZc9ackha03Z4m3FmIoyeBRFY4Z-Hs6sDFH, Instagram https://www.globenewswire.com/Tracker?data=--FPN6c_4ynGq-s7VUGeP-dPWXAzXTF0F3qG80RqhcYwgLvt3ioDsYmrmlv2GHOu2MosYL3aJkztVH7TmSuvO9FimckHHw8LtR3D5c581TY=, YouTube https://www.globenewswire.com/Tracker?data=3LNISKb2Ngrb2-Pdf4Ed5Av9O-YYRTNiidWrB1Bx4G8q-99dNNLDDaPZcDmMdnYBx68th7365HSG7WLSC7lft6j0PGdSwYkfGJoJViIZngQ=, and TikTok https://www.globenewswire.com/Tracker?data=L40dtwJTl37McJYCkWfCsnozoduYL_GIg1A8rta7fZwvlhqpGicW2iHa7OJ1hPGVWj8J0m-VmL0pWjCEXJSDTqa3c2fnYbcge4uwSVXCtXw=.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040730PRIMZONEFULLFEED9665372) on March 04, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment